In patients with diabetic polyneuropathy, Cerebrolysin showed significant therapeutic effectiveness for unspecified measured parameters.
In plain wordsIn patients with diabetic polyneuropathy, Cerebrolysin showed benefits for some measured parameters, which the abstract does not identify.
- Peptide
- Cerebrolysin
- Outcome
- Direction not reportedUnspecified polyneuropathy parameters
- Study
n = 60
- Comparator
- Milgamma
- Outcome group
- Neuroprotection · Nervous system and cognition
- Studied dose
- Dose not stated
Source sentences
The significant therapeutic effectiveness of cerebrolysin was revealed for some parameters measured.
1 context sentence(design, population, supporting numbers)
60 patients with clinical features of symmetric diabetic polyneuropathy have been examined including 30 patients of main group who received cerebrolysin and 30 patients of control group treated with milgamma.